At a glance
ClinicalIndex Comparison RecordN/ACompleted· 275 enrolled
Drug / intervention
Fluency Plus Endovascular Stent Graft +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective, Multi-Center, Randomized, Concurrently-Controlled Study of the FLUENCY® PLUS Endovascular Stent Graft in the Treatment of In-stent Restenosis in the Arteriovenous (AV) Access Venous Outflow Circuit (RESCUE)
In Brief
A clinical study evaluating Fluency Plus Endovascular Stent Graft and Percutaneous Transluminal Angioplasty only for Restenosis. Completed, enrolled 275 participants across 23 sites.
Detailed Summary
The primary purpose of this study is to demonstrate that the FLUENCY® PLUS Endovascular Stent Graft can effectively and safely treat in-stent restenotic lesions in the venous outflow of the Arteriovenous (AV) access circuit of hemodialysis patients with either of the two predominant vascular access types - those with an AV graft and those with an AV fistula.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRestenosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2010
First PostedDec 2010
Primary CompletionNov 2013
Study CompletionJan 2016
TodayJul 2026
First PostedDec 9, 2010
Enrollment StartDec 1, 2010
Primary CompletionNov 1, 2013
Study CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 15.6 years ago
Interventions
Fluency Plus Endovascular Stent Graftdevice
Treatment of in-stent restenosis
Percutaneous Transluminal Angioplasty onlydevice
Treatment of in-stent restenosis